KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

HCA Healthcare (HCA) EBIAT (2016 - 2025)

HCA Healthcare (HCA) has disclosed EBIAT for 16 consecutive years, with $1.9 billion as the latest value for Q4 2025.

  • On a quarterly basis, EBIAT rose 11.39% to $1.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $6.8 billion, a 9.07% increase, with the full-year FY2025 number at $6.8 billion, up 1.91% from a year prior.
  • EBIAT was $1.9 billion for Q4 2025 at HCA Healthcare, up from $1.2 billion in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $2.6 billion in Q4 2022 to a low of $680.0 million in Q3 2023.
  • A 5-year average of $1.6 billion and a median of $1.6 billion in 2023 define the central range for EBIAT.
  • Peak YoY movement for EBIAT: plummeted 49.4% in 2023, then soared 117.94% in 2024.
  • HCA Healthcare's EBIAT stood at $1.8 billion in 2021, then surged by 45.87% to $2.6 billion in 2022, then tumbled by 39.27% to $1.6 billion in 2023, then rose by 4.92% to $1.7 billion in 2024, then grew by 11.39% to $1.9 billion in 2025.
  • Per Business Quant, the three most recent readings for HCA's EBIAT are $1.9 billion (Q4 2025), $1.2 billion (Q3 2025), and $2.1 billion (Q2 2025).